When treating people with Type Two Diabetes, doctors sometimes prescribe high doses of medications that lower blood sugar. The American Diabetes Association recommends good control of blood sugars in order to reduce the risk of heart attacks. But recently part of a large clinical diabetes study was halted after researchers found an increased death rate among those taking higher doses of blood sugar lowering medication. The ACCORD trial, as it is called, is funded by several U.S. government agencies and the finding surprised many doctors.
The surprise death rate has lead some U.S. physicians to push an uncommon diet as a way to lower blood sugar. VOA's Shelley Schlender reports from Phoenix, Arizona.